Publications by authors named "Devangere P Devanand"

Claim this Profile
A
A proof-of-concept study: investigating the impact of COMT genotype and proline on negative symptoms in Alzheimer's disease.
James D Clelland, Hector W Cure, Ashley M Canizares, Julia H Anderson, Bimala Rawal, Devangere P Devanand

BJPsych Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjective versus Psychophysical Measures of Chemosensory Alterations following COVID-19.
Brandon J Vilarello, Patricia T Jacobson, Clayton J Snyder, Tse-Hwei Choo, Liam W Gallagher, Devangere P Devanand

ORL J Otorhinolaryngol Relat Spec· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Improvement after Cognitive Training in Mild Cognitive Impairment: Insights from the Cognitive Training and Neuroplasticity in Mild Cognitive Impairment Trial.
Min Qian, Jeffrey Motter, Emily Deehan, Jamie Graff, Alisa Adhikari, Devangere P Devanand

Alzheimer Dis Assoc Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel Recommendations.
Harris A Eyre, Lucy E Stirland, Dilip V Jeste, Charles F Reynolds, Michael Berk, Devangere P Devanand

Am J Geriatr Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning improves utility of tau PET in the study of Alzheimer's disease.
James Zou, David Park, Aubrey Johnson, Xinyang Feng, Michelle Pardo, Devangere P Devanand

Alzheimers Dement (Amst)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
Thang Ho, Bruce G Pollock, Benoit H Mulsant, Oliver Schantz, Devangere P Devanand

Br J Clin Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
Daniel Weintraub, Lea T Drye, Anton P Porsteinsson, Paul B Rosenberg, Bruce G Pollock, Devangere P Devanand

Am J Geriatr Psychiatry· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depressive symptoms, vascular risk factors, and Alzheimer's disease.
José A Luchsinger, Lawrence S Honig, Ming-Xin Tang, Devangere P Devanand

Int J Geriatr Psychiatry· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly.
Elan D Louis, Karen Marder, Matthias H Tabert, Devangere P Devanand

Mov Disord· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke, depression, and functional health outcomes among adults in the community.
Renee D Goodwin, Devangere P Devanand

J Geriatr Psychiatry Neurol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol.
Gregory H Pelton, Devangere P Devanand, Karen Bell, Karen Marder, Kristin Marston

Am J Geriatr Psychiatry· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis